. Author manuscript; available in PMC: 2017 Jul 1.

Published in final edited form as: J Pediatr. 2016 Apr 19;174:98–103.e1. doi: 10.1016/j.jpeds.2016.03.035

Table 2.

Medication use by seizure etiology among 426 neonates with clinically suspected and/or EEG confirmed seizures who were monitored by cEEG.

	Phenobarbital	Levetiracetam	Fosphenytoin
Term	346 (93%)	116 (31%)	109 (29%)
Preterm	47 (89%)	18 (34%)	10 (19%)
Hypoxic ischemic encephalopathy	153 (94%)	45 (28%)	44 (27%)
Ischemic stroke	71 (95%)	23 (31%)	28 (37%)
Intracranial hemorrhage	45 (92%)	19 (39%)	17 (35%)
Epileptic encephalopathy/Genetic epilepsy	23 (96%)	15 (63%)	6 (25%)
Intracranial infection	18 (95%)	9 (47%)	4 (21%)
Brain Malformation	18 (100%)	10 (56%)	8 (44%)
Benign familial neonatal epilepsy	9 (82%)	1 (9%)	0
Inborn error of metabolism	10 (77%)	3 (23%)	2 (15%)
Transient metabolic (hypoglycemia or electrolyte disturbance)	15 (93%)	2 (13%)	3 (19%)
Other/Unknown	31 (82%)	7 (18%)	7 (18%)

Data are presented as N and row %